07 Lessons from transplantation: Multitargeted therapy for proliferative lupus nephritis

07 Lessons from transplantation: Multitargeted therapy for proliferative lupus nephritis

Bibliographic Details
Main Author:	Daniel Tak Mao Chan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-04-01
Series:	Lupus Science and Medicine

Similar Items

Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis
by: Tianbiao Zhou, et al.
Published: (2019-10-01)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
by: Oh Chan Kwon, et al.
Published: (2020-06-01)

The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
by: Susan Yung, et al.
Published: (2012-01-01)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
by: Dong-Ni Chen, et al.
Published: (2018-01-01)

Diffuse proliferative crescentic lupus nephritis with normal renal function
by: Vibhanshu Gupta, et al.
Published: (2012-01-01)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
by: S. W. Olson, et al.
Published: (2017-01-01)

Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa
by: Phelisa Sogayise, et al.
Published: (2020-01-01)

POS-243 THE VALUE OF AUTOANTIBODIES AS PREDICTORS FOR PROLIFERATIVE LUPUS NEPHRITIS CLASSES
by: N. LADHARI, et al.
Published: (2021-04-01)

The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial
by: Lauren Galbraith, et al.
Published: (2014-11-01)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
by: Mina Rina, et al.
Published: (2012-07-01)

Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis
by: Ross Sophia, et al.
Published: (2012-08-01)

Comparison of two steroid regimens in induction therapy of proliferative lupus nephritis: A randomized controlled trial
by: Joyita Bharati, et al.
Published: (2019-01-01)

Autoantibodies and Resident Renal Cells in the Pathogenesis of Lupus Nephritis: Getting to Know the Unknown
by: Susan Yung, et al.
Published: (2012-01-01)

Individualizing Therapy in Lupus Nephritis
by: Yu An, et al.
Published: (2019-10-01)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
by: Trivedi Hargovind L, et al.
Published: (2008-02-01)

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
by: Robert Nee, et al.
Published: (2015-01-01)

Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies
by: Tak Mao eChan, et al.
Published: (2015-09-01)

Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India
by: D Sircar, et al.
Published: (2013-01-01)

Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01)

Mediators of Inflammation and Their Effect on Resident Renal Cells: Implications in Lupus Nephritis
by: Susan Yung, et al.
Published: (2013-01-01)

Diagnostic Determinants of Proliferative Lupus Nephritis Based on Clinical and Laboratory Parameters: A Diagnostic Study
by: Aida Lydia, et al.
Published: (2018-06-01)

Establishing Clinical Variables towards the Development of Corticosteroid Treatment Algorithms in Pediatric Proliferative Lupus Nephritis
by: Chalhoub, Nathalie E.
Published: (2019)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
by: Nicholas L. Li, et al.
Published: (2021-02-01)

A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies [version 1; peer review: 2 approved]
by: Susan Yung, et al.
Published: (2020-08-01)

Induction therapy and outcome of proliferative lupus nephritis in the top end of Northern Australia – a single centre study retrospective study
by: Abeyaratne, A., et al.
Published: (2022)

Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
by: Dawn J. Caster, et al.
Published: (2021-02-01)

Mesangial cell-binding activity of serum immunoglobulin g in patients with lupus nephritis.
by: Desmond Y H Yap, et al.
Published: (2014-01-01)

Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis [version 1; referees: 2 approved]
by: Susan Yung, et al.
Published: (2017-06-01)

Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
by: Jennifer C Cooper, et al.
Published: (2018-10-01)

19 Lupus nephritis
by: Liz Lightstone, et al.
Published: (2021-04-01)

Management of Lupus Nephritis
by: Farah Tamirou, et al.
Published: (2021-02-01)

Pediatric lupus nephritis
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2018-11-01)

Management of Lupus Nephritis
by: Merkel F, et al.
Published: (2000-01-01)

Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01)

An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
by: Wenchao Li, et al.
Published: (2021-02-01)

B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis
by: Desmond Y. H. Yap, et al.
Published: (2020-09-01)

Renal transplant in a lupus nephritis patient with β-thalassemia trait
by: Uma Shankar Gaur, et al.
Published: (2017-01-01)

Urinary biomarkers in lupus nephritis
by: Cristian C. Aragón, et al.
Published: (2020-01-01)

The Role of Cytokine in the Lupus Nephritis
by: Yasunori Iwata, et al.
Published: (2011-01-01)

Antiphospholipid Antibodies in Lupus Nephritis.
by: Ioannis Parodis, et al.
Published: (2016-01-01)